Wearable Devices Ltd. Secures $750,000 Israel Innovation Authority Grant for Neural Rehabilitation Pilot Study
TL;DR
Wearable Devices gains a $750,000 grant for a clinical pilot, potentially establishing its Mudra Link as a leading rehabilitation tool and creating a competitive edge in the medical tech market.
The clinical pilot will use Wearable Devices' patented surface EMG technology in the Mudra Link wristband to quantitatively monitor neuro-muscular activity for grip-force control rehabilitation.
This technology aims to improve accessibility and outcomes in therapy for patients with motor-cortex injuries, making rehabilitation more effective and enhancing their quality of life.
A wristband that reads muscle signals is being tested to help patients regain hand control, blending AI wearables with advanced medical rehabilitation.
Found this article helpful?
Share it with your network and spread the knowledge!
Wearable Devices Ltd. (NASDAQ: WLDS), a technology company specializing in AI-powered touchless sensing wearables, announced approval from the Israel Innovation Authority for a $750,000 budget to support a clinical pilot program. The study will be conducted in collaboration with Soroka University Medical Center and will evaluate the company's Mudra Link neural wristband as a rehabilitation tool for patients with impaired grip-force control following motor-cortex injuries.
The grant enables the extension of Wearable Devices' patented surface electromyography (EMG) technology into quantitative neuro-muscular monitoring applications. This advancement aims to improve accessibility, tracking, and outcomes in force-control therapy for patients recovering from neurological injuries. The clinical pilot represents a significant expansion of the company's technology platform beyond consumer applications into the healthcare and rehabilitation sectors.
Wearable Devices has established itself as a pioneer in human-computer interaction through its AI-powered neural input touchless technology. The company's consumer products, including the Mudra Band and Mudra Link, utilize proprietary sensors, software, and advanced AI algorithms to enable touch-free, intuitive control of digital devices using gestures across multiple operating systems. These products have helped define the neural input category for both wrist-worn devices and brain-computer interfaces.
The company operates through a dual-channel business model that includes direct-to-consumer sales and enterprise licensing and collaborations. This approach allows Wearable Devices to serve both individual consumers seeking enhanced experiences in gaming, productivity, and extended reality (XR) applications, as well as enterprise partners requiring advanced input solutions for immersive and interactive environments. The company's technology has applications across augmented reality, virtual reality, XR, and smart environments.
The Israel Innovation Authority grant represents a strategic validation of Wearable Devices' technology platform and its potential applications in medical rehabilitation. By applying neural input technology to clinical settings, the company is positioning itself at the intersection of consumer electronics and healthcare technology, two rapidly growing sectors. The successful implementation of this pilot could establish new standards for neural input applications in therapeutic contexts and expand the company's market opportunities beyond consumer electronics.
Wearable Devices' ordinary shares and warrants trade on the Nasdaq Capital Market under the symbols "WLDS" and "WLDSW," respectively. The company maintains a newsroom at https://ibn.fm/WLDS where investors can access the latest updates and information. The press release announcing the grant was distributed through InvestorWire, a specialized communications platform that is part of the Dynamic Brand Portfolio at IBN, which provides wire-grade press release syndication and corporate communications solutions to private and public companies.
Curated from InvestorBrandNetwork (IBN)
